J. L. Bainbridge & Co. Inc. lowered its stake in Bristol-Myers Squibb ( NYSE:BMY – Get Rating ) by 0.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 303,693 shares of the biopharmaceutical company's stock after selling 551 shares during the period. Bristol-Myers Squibb accounts for 3.4% of J. L. Bainbridge & Co. Inc.'s holdings, making the stock its 14th largest holding. J. L. Bainbridge & Co.

https://www.dailypolitical.com/2023/04/08/j-l-bainbridge-co-inc-has-21-85-million-stock-position-in-bristol-myers-squibb-nysebmy.html

#dailypolitical